Skip to content

Pudendal Block Versus Penian Block For Circumcision In Children

Pudendal Block Versus Penian Block For Circumcision In Children: A Double Blind Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03046290
Enrollment
60
Registered
2017-02-08
Start date
2017-01-31
Completion date
2017-04-30
Last updated
2017-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circumcision, Postoperative Pain, Regional Anesthesia

Brief summary

The authors study the efficacy of the pudendal versus penile block for the relief of postoperative pain in children receiving ambulatory circumcision. In this prospective, double-blind, randomized, parallel-arm trial, 60 children recruited during the anesthesia consultation will be allocated a general anesthesia with a pudendal block (PUD group) or a penile block (PEN group). Each block will be made with equal parts lidocaine 1% and ropivacaine 0.75% (0.3 ml/kg).

Interventions

PROCEDUREcircumcision
DRUGLidocaine
DRUGRopivacaine

Sponsors

Université Libre de Bruxelles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
MALE
Age
1 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* circumcision in day surgery hospital

Exclusion criteria

* allergy to amino-amide local anesthetics * parental consent not received * infection at injection site

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain scorepain score at 0 hours postoperativelyusing the FLACC (Face Leg Activity Cry Consolability) Scale

Secondary

MeasureTime frameDescription
Degree of satisfaction of the patient or his/her parents and the surgeon assessed by telephone interviewDay 5 after the proceduretelephone interview

Countries

Belgium

Contacts

Primary ContactJohn Nicolardot, MD
nicolardotjohn@gmail.com+3225555288
Backup ContactJohn Nicolardot
nicolardotjohn@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026